8-K Announcements
6Material company update
Apr 24, 2026·SEC
Material company update
Feb 25, 2026·SEC
Material company update
Jan 27, 2026·SEC
HCA Healthcare, Inc.(HCA)Earnings, Financials & Key Ratios
HCA•NYSE
13.2× P/E·Price updated Jun 19, 2026
AboutHCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.Show more
- Revenue$75.6B+7.1%
- EBITDA$15.49B+11.8%
- Net Income$6.78B+17.8%
- EPS (Diluted)28.38+29.0%
- Gross Margin41.5%+2.2%
- EBITDA Margin20.49%+4.4%
- Operating Margin15.83%+5.9%
- Net Margin8.97%+10.0%
HCA Key Insights
HCA Healthcare, Inc. (HCA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 887.8%
- ✓Strong Piotroski F-Score: 7/9
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 11.9% through buybacks
- ✓Efficient asset utilization: 1.2x turnover
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when HCA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HCA Price & Volume
HCA Healthcare, Inc. (HCA) stock price & volume — 10-year historical chart
Loading chart...
HCA Growth Metrics
HCA Healthcare, Inc. (HCA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.66%
5 Years7.97%
3 Years7.87%
TTM7.08%
Profit CAGR
10 Years12.29%
5 Years12.56%
3 Years6.33%
TTM17.78%
EPS CAGR
10 Years18.98%
5 Years21.03%
3 Years14.01%
TTM29.06%
Return on Capital
10 Years22.38%
5 Years23.84%
3 Years24.45%
Last Year26.98%
HCA Recent Earnings
HCA Healthcare, Inc. (HCA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 24, 2026Metric
Actual
Est
EPS
$7.15+0.4%
$7.12
Rev
$19.1B+0.1%
$19.1B
Q1 2026
Jan 27, 2026Metric
Actual
Est
EPS
$8.01+7.4%
$7.46
Rev
$19.5B-0.9%
$19.7B
Q4 2025
Oct 24, 2025Metric
Actual
Est
EPS
$6.96+20.2%
$5.79
Rev
$19.2B+3.0%
$18.6B
Q3 2025
Jul 25, 2025Metric
Actual
Est
EPS
$6.84+8.7%
$6.29
Rev
$18.6B+0.6%
$18.5B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 24, 2026 | $7.15vs $7.12+0.4% | $19.1Bvs $19.1B+0.1% |
| Q1 2026 | Jan 27, 2026 | $8.01vs $7.46+7.4% | $19.5Bvs $19.7B-0.9% |
| Q4 2025 | Oct 24, 2025 | $6.96vs $5.79+20.2% | $19.2Bvs $18.6B+3.0% |
| Q3 2025 | Jul 25, 2025 | $6.84vs $6.29+8.7% | $18.6Bvs $18.5B+0.6% |
Based on last 12 quarters of dataView full earnings history →
HCA Peer Comparison
HCA Healthcare, Inc. (HCA) competitors in Hospitals and inpatient facilities — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 THC | 15.12B | 172.57 | 11.14 | 3.12% | 7.94% | 19.56% | 1.47 | |
 CYH | 425.61M | 3.02 | 0.80 | -1.18% | -0.41% | |||
 UHS | 8.84B | 141.17 | 6.11 | 9.71% | 8.56% | 20.65% | 0.74 | |
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 | |
 SEM | 2.05B | 16.54 | 14.02 | 5.12% | 2.42% | 6.57% | 1.82 | |
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 SGRY | 1.9B | 14.55 | -23.85 | 6.24% | -2.28% | -2.15% | 1.14 | |
 USPH | 964.39M | 63.32 | 44.59 | 16.33% | 1.52% | 1.36% | 0.55 |
Compare HCA vs Peers
HCA Healthcare, Inc. (HCA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HCA Income Statement
HCA Healthcare, Inc. (HCA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 43.61B | 46.68B | 51.34B | 51.53B | 58.75B | 60.23B | 64.97B | 70.6B | 75.6B |
Revenue Growth % | 5.12% | 7.02% | 9.98% | 0.38% | 14.01% | 2.52% | 7.86% | 8.67% | 7.08% |
Cost of Goods Sold | 7.32B | 7.72B | 8.48B | 8.37B | 36.26B | 37.06B | 39.39B | 41.92B | 44.23B |
COGS % of Revenue | 16.77% | 16.55% | 16.52% | 16.24% | 61.72% | 61.52% | 60.63% | 59.38% | 58.5% |
Gross Profit | 36.3B▲ 0% | 38.95B▲ 7.3% | 42.85B▲ 10.0% | 43.16B▲ 0.7% | 22.49B▼ 47.9% | 23.18B▲ 3.0% | 25.58B▲ 10.4% | 28.68B▲ 12.1% | 31.37B▲ 9.4% |
Gross Margin % | 83.23% | 83.45% | 83.48% | 83.76% | 38.28% | 38.48% | 39.37% | 40.62% | 41.5% |
Gross Profit Growth % | 5.04% | 7.31% | 10.02% | 0.72% | -47.89% | 3.05% | 10.36% | 12.12% | 9.4% |
Operating Expenses | 30.24B | 32.31B | 35.64B | 35.9B | 12.81B | 14.12B | 15.95B | 18.13B | 19.41B |
OpEx % of Revenue | 69.34% | 69.22% | 69.42% | 69.67% | 21.81% | 23.45% | 24.55% | 25.68% | 25.67% |
Selling, General & Admin | 20.06B | 21.43B | 23.56B | 23.87B | 26.78B | 27.68B | 29.49B | 31.17B | 8B |
SG&A % of Revenue | 45.99% | 45.9% | 45.89% | 46.33% | 45.58% | 45.96% | 45.39% | 44.15% | 10.58% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 10.18B | 10.89B | 12.08B | 12.03B | -13.96B | -13.56B | -13.54B | -13.04B | 11.41B |
Operating Income | 6.06B▲ 0% | 6.64B▲ 9.7% | 7.22B▲ 8.7% | 7.26B▲ 0.6% | 9.68B▲ 33.3% | 9.05B▼ 6.5% | 9.63B▲ 6.3% | 10.55B▲ 9.6% | 11.96B▲ 13.4% |
Operating Margin % | 13.89% | 14.23% | 14.06% | 14.09% | 16.47% | 15.03% | 14.82% | 14.94% | 15.83% |
Operating Income Growth % | -2.27% | 9.66% | 8.67% | 0.61% | 33.27% | -6.46% | 6.34% | 9.56% | 13.44% |
EBITDA | 8.19B | 8.92B | 9.81B | 9.98B | 12.53B | 12.02B | 12.7B | 13.86B | 15.49B |
EBITDA Margin % | 18.77% | 19.11% | 19.12% | 19.37% | 21.33% | 19.96% | 19.55% | 19.63% | 20.49% |
EBITDA Growth % | 0.29% | 8.94% | 10.02% | 1.72% | 25.52% | -4.06% | 5.67% | 9.09% | 11.75% |
D&A (Non-Cash Add-back) | 2.13B | 2.28B | 2.6B | 2.72B | 2.85B | 2.97B | 3.08B | 3.31B | 3.52B |
EBIT | 6.07B | 7.09B | 7.07B | 7.01B | 11.4B | 10.32B | 9.64B | 10.58B | 12.08B |
Net Interest Income | -1.67B | -1.76B | -1.84B | -1.56B | -1.53B | -1.74B | -1.94B | -2.06B | -2.25B |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 1.67B | 1.76B | 1.84B | 1.56B | 1.53B | 1.74B | 1.94B | 2.06B | 2.25B |
Other Income/Expense | -1.68B | -1.31B | -1.97B | -1.83B | 155M | -473M | -1.92B | -2.02B | -2.13B |
Pretax Income | 4.38B▲ 0% | 5.33B▲ 21.8% | 5.24B▼ 1.7% | 5.43B▲ 3.5% | 9.83B▲ 81.1% | 8.58B▼ 12.7% | 7.71B▼ 10.2% | 8.52B▲ 10.6% | 9.83B▲ 15.4% |
Pretax Margin % | 10.04% | 11.43% | 10.22% | 10.54% | 16.74% | 14.24% | 11.86% | 12.07% | 13.01% |
Income Tax | 1.64B | 946M | 1.1B | 1.04B | 2.11B | 1.75B | 1.61B | 1.87B | 2.05B |
Effective Tax Rate % | 37.39% | 17.73% | 20.96% | 19.21% | 21.48% | 20.35% | 20.96% | 21.89% | 20.85% |
Net Income | 2.22B▲ 0% | 3.79B▲ 70.9% | 3.5B▼ 7.4% | 3.75B▲ 7.1% | 6.96B▲ 85.3% | 5.64B▼ 18.9% | 5.24B▼ 7.1% | 5.76B▲ 9.9% | 6.78B▲ 17.8% |
Net Margin % | 5.08% | 8.11% | 6.83% | 7.28% | 11.84% | 9.37% | 8.07% | 8.16% | 8.97% |
Net Income Growth % | -23.32% | 70.89% | -7.45% | 7.1% | 85.3% | -18.88% | -7.11% | 9.88% | 17.78% |
Net Income (Continuing) | 2.74B | 4.39B | 4.14B | 4.39B | 7.72B | 6.83B | 6.09B | 6.66B | 7.78B |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 1.81B | 2.03B | 2.24B | 2.32B | 2.42B | 2.69B | 2.83B | 3.05B | 3.26B |
EPS (Diluted) | 5.95▲ 0% | 10.66▲ 79.2% | 10.07▼ 5.5% | 10.93▲ 8.5% | 21.16▲ 93.6% | 19.15▼ 9.5% | 18.96▼ 1.0% | 22.00▲ 16.0% | 28.38▲ 29.0% |
EPS Growth % | -18.49% | 79.16% | -5.53% | 8.54% | 93.6% | -9.5% | -0.99% | 16.03% | 29% |
EPS (Basic) | 6.33 | 11.04 | 10.27 | 11.08 | 21.51 | 19.44 | 19.24 | 22.27 | 28.62 |
Diluted Shares Outstanding | 372.22M | 355.3M | 348.23M | 345.37M | 328.75M | 294.67M | 276.41M | 261.81M | 230.71M |
Basic Shares Outstanding | 350.09M | 342.9M | 341.21M | 339.43M | 323.31M | 290.35M | 272.4M | 258.6M | 230.71M |
Dividend Payout Ratio | - | 12.86% | 15.69% | 4.08% | 8.97% | 11.57% | 12.61% | 11.98% | 10.01% |
HCA Balance Sheet
HCA Healthcare, Inc. (HCA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 9.98B | 10.21B | 11.2B | 12.33B | 13.54B | 13.64B | 14.93B | 16.41B | 13.56B |
Cash & Short-Term Investments | 732M | 502M | 621M | 1.79B | 1.45B | 908M | 935M | 2.02B | 1.04B |
Cash Only | 732M | 502M | 621M | 1.79B | 1.45B | 908M | 935M | 1.93B | 1.04B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88M | 0 |
Accounts Receivable | 6.5B | 6.79B | 7.38B | 7.05B | 8.1B | 8.89B | 9.96B | 10.75B | 10.87B |
Days Sales Outstanding | 54.41 | 53.09 | 52.47 | 49.94 | 50.29 | 53.88 | 55.95 | 55.58 | 52.47 |
Inventory | 1.57B | 1.73B | 1.85B | 2.02B | 1.99B | 2.07B | 2.02B | 1.74B | 1.65B |
Days Inventory Outstanding | 78.48 | 81.85 | 79.58 | 88.32 | 19.99 | 20.37 | 18.73 | 15.13 | 13.63 |
Other Current Assets | 1.17B | 1.19B | 1.35B | 1.46B | 2.01B | 1.78B | 2.01B | 1.9B | 0 |
Total Non-Current Assets | 26.62B | 28.99B | 33.86B | 35.16B | 37.2B | 38.8B | 41.28B | 43.1B | 47.16B |
Property, Plant & Equipment | 17.89B | 19.76B | 24.55B | 25.22B | 26.18B | 27.64B | 29.92B | 31.55B | 31.14B |
Fixed Asset Turnover | 2.44x | 2.36x | 2.09x | 2.04x | 2.24x | 2.18x | 2.17x | 2.24x | 2.43x |
Goodwill | 7.04B | 7.61B | 7.94B | 8.21B | 9.14B | 9.29B | 9.61B | 9.77B | 0 |
Intangible Assets | 359M | 342M | 330M | 369M | 403M | 359M | 339M | 323M | 10.29B |
Long-Term Investments | 617M | 594M | 564M | 810M | 886M | 1.2B | 1.23B | 1.23B | 633M |
Other Non-Current Assets | 710M | 690M | 480M | 546M | 598M | 298M | 184M | 230M | 5.09B |
Total Assets | 36.59B▲ 0% | 39.21B▲ 7.1% | 45.06B▲ 14.9% | 47.49B▲ 5.4% | 50.74B▲ 6.8% | 52.44B▲ 3.3% | 56.21B▲ 7.2% | 59.51B▲ 5.9% | 60.72B▲ 2.0% |
Asset Turnover | 1.19x | 1.19x | 1.14x | 1.09x | 1.16x | 1.15x | 1.16x | 1.19x | 1.25x |
Asset Growth % | 8.4% | 7.14% | 14.92% | 5.4% | 6.85% | 3.34% | 7.2% | 5.87% | 2.03% |
Total Current Liabilities | 6.16B | 7.57B | 7.76B | 8.7B | 9.58B | 9.9B | 12.65B | 15.18B | 16.35B |
Accounts Payable | 2.61B | 2.58B | 2.9B | 3.54B | 4.11B | 4.24B | 4.23B | 4.28B | 4.66B |
Days Payables Outstanding | 130.01 | 121.78 | 125.02 | 154.17 | 41.38 | 41.75 | 39.23 | 37.23 | 38.45 |
Short-Term Debt | 200M | 788M | 145M | 209M | 237M | 370M | 2.42B | 4.7B | 6.74B |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 67M | 459M | 528M | 547M | 549M | 794M | 867M | 910M | 2.42B |
Current Ratio | 1.62x | 1.35x | 1.44x | 1.42x | 1.41x | 1.38x | 1.18x | 1.08x | 0.83x |
Quick Ratio | 1.36x | 1.12x | 1.20x | 1.18x | 1.21x | 1.17x | 1.02x | 0.97x | 0.73x |
Cash Conversion Cycle | 2.87 | 13.16 | 7.02 | -15.91 | 28.9 | 32.49 | 35.45 | 33.48 | 27.65 |
Total Non-Current Liabilities | 35.43B | 34.56B | 37.87B | 35.89B | 39.67B | 42.61B | 42.5B | 43.78B | 47.14B |
Long-Term Debt | 32.86B | 32.03B | 33.58B | 30.8B | 33.77B | 37.13B | 37.17B | 38.33B | 41.6B |
Capital Lease Obligations | 0 | 0 | 1.5B | 1.67B | 2.33B | 2.33B | 1.9B | 1.86B | 1.85B |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2.57B | 2.52B | 2.79B | 3.43B | 3.57B | 3.14B | 3.42B | 3.58B | 3.69B |
Total Liabilities | 41.59B | 42.13B | 45.62B | 44.6B | 49.25B | 52.51B | 55.15B | 58.96B | 63.49B |
Total Debt | 33.06B | 32.82B | 35.57B | 33.06B | 36.73B | 40.2B | 41.86B | 45.24B | 50.2B |
Net Debt | 32.33B | 32.32B | 34.95B | 31.26B | 35.27B | 39.29B | 40.92B | 43.3B | 49.16B |
Debt / Equity | - | - | - | 11.43x | 24.66x | - | 39.49x | 81.51x | - |
Debt / EBITDA | 4.04x | 3.68x | 3.62x | 3.31x | 2.93x | 3.34x | 3.29x | 3.26x | 3.24x |
Net Debt / EBITDA | 3.95x | 3.62x | 3.56x | 3.13x | 2.82x | 3.27x | 3.22x | 3.12x | 3.17x |
Interest Coverage | 3.64x | 4.02x | 3.84x | 4.50x | 7.46x | 5.94x | 4.98x | 5.14x | 5.37x |
Total Equity | -5B▲ 0% | -2.92B▲ 41.6% | -565M▲ 80.6% | 2.89B▲ 611.9% | 1.49B▼ 48.5% | -73M▼ 104.9% | 1.06B▲ 1552.1% | 555M▼ 47.6% | -2.77B▼ 599.3% |
Equity Growth % | 11.33% | 41.58% | 80.64% | 611.86% | -48.51% | -104.9% | 1552.05% | -47.64% | -599.28% |
Book Value per Share | -13.42 | -8.21 | -1.62 | 8.37 | 4.53 | -0.25 | 3.83 | 2.12 | -12.01 |
Total Shareholders' Equity | -6.81B | -4.95B | -2.81B | 572M | -933M | -2.77B | -1.77B | -2.5B | -6.03B |
Common Stock | 4M | 3M | 3M | 3M | 3M | 3M | 3M | 3M | 2M |
Retained Earnings | -6.53B | -4.57B | -2.35B | 777M | -532M | -2.28B | -1.35B | -2.12B | -5.72B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -278M | -381M | -460M | -502M | -404M | -490M | -425M | -387M | -305M |
Minority Interest | 1.81B | 2.03B | 2.24B | 2.32B | 2.42B | 2.69B | 2.83B | 3.05B | 3.26B |
HCA Cash Flow Statement
HCA Healthcare, Inc. (HCA) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 5.43B | 6.76B | 7.6B | 9.23B | 8.96B | 8.52B | 9.43B | 10.51B | 12.64B |
Operating CF Margin % | 12.44% | 14.48% | 14.81% | 17.91% | 15.25% | 14.15% | 14.52% | 14.89% | 16.71% |
Operating CF Growth % | -4.02% | 24.6% | 12.44% | 21.44% | -2.96% | -4.88% | 10.67% | 11.48% | 20.18% |
Net Income | 2.74B | 4.39B | 4.14B | 4.39B | 7.72B | 6.83B | 5.24B | 6.66B | 6.78B |
Depreciation & Amortization | 2.13B | 2.28B | 2.6B | 2.72B | 2.85B | 2.97B | 3.08B | 3.31B | 3.52B |
Stock-Based Compensation | 270M | 268M | 347M | 362M | 440M | 341M | 262M | 360M | 0 |
Deferred Taxes | 433M | 74M | 250M | 41M | -70M | 571M | 229M | 22M | 0 |
Other Non-Cash Items | 145M | -281M | 352M | 443M | -1.48B | -1.04B | 1.08B | 269M | 1.6B |
Working Capital Changes | -296M | 33M | -88M | 1.28B | -503M | -1.15B | -457M | -106M | 728M |
Change in Receivables | -4.64B | -423M | -326M | 327M | -962M | -797M | 0 | -799M | -94M |
Change in Inventory | -69M | -242M | -158M | -304M | -540M | -59M | 0 | 334M | -154M |
Change in Payables | 374M | 698M | 396M | 1.25B | 999M | -296M | 0 | 359M | 666M |
Cash from Investing | -4.28B | -3.9B | -5.72B | -3.39B | -2.64B | -3.39B | -5.32B | -4.93B | -4.99B |
Capital Expenditures | -3.02B | -3.57B | -4.16B | -2.83B | -3.58B | -4.39B | -4.74B | -4.88B | -4.94B |
CapEx % of Revenue | 6.91% | 7.65% | 8.1% | 5.5% | 6.09% | 7.3% | 7.3% | 6.9% | 6.54% |
Acquisitions | -1.21B | -445M | -1.62B | -500M | 1.05B | 1.01B | -442M | 0 | -128M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -52M | 60M | 59M | -58M | -121M | -7M | -131M | -58M | 12M |
Cash from Financing | -1.06B | -3.08B | -1.77B | -4.68B | -6.66B | -5.66B | -4.09B | -4.58B | -8.55B |
Debt Issued (Net) | 1.51B | -344M | 567M | -3.22B | 3.25B | 3.29B | 1.29B | 3.21B | 3.21B |
Equity Issued (Net) | -2.05B | -1.53B | -1.03B | -441M | -8.21B | -7B | -3.81B | -6.04B | -10.07B |
Dividends Paid | 0 | -487M | -550M | -153M | -624M | -653M | -661M | -690M | -679M |
Share Repurchases | -2.05B | -1.53B | -1.03B | -441M | -8.21B | -7B | -3.81B | -6.04B | -10.07B |
Other Financing | -519M | -714M | -757M | -866M | -1.07B | -1.29B | -917M | -1.05B | -1.01B |
Net Change in Cash | 86M▲ 0% | -230M▼ 367.4% | 119M▲ 151.7% | 1.17B▲ 884.9% | -342M▼ 129.2% | -543M▼ 58.8% | 27M▲ 105.0% | 998M▲ 3596.3% | -893M▼ 189.5% |
Free Cash Flow | 2.41B▲ 0% | 3.19B▲ 32.2% | 3.44B▲ 8.0% | 6.4B▲ 85.7% | 5.38B▼ 15.9% | 4.13B▼ 23.3% | 4.69B▲ 13.6% | 5.64B▲ 20.3% | 7.69B▲ 36.4% |
FCF Margin % | 5.53% | 6.83% | 6.71% | 12.41% | 9.16% | 6.85% | 7.21% | 7.99% | 10.17% |
FCF Growth % | -16.66% | 32.23% | 8.03% | 85.74% | -15.87% | -23.32% | 13.57% | 20.31% | 36.41% |
FCF per Share | 6.48 | 8.97 | 9.89 | 18.52 | 16.37 | 14.01 | 16.96 | 21.54 | 33.34 |
FCF Conversion (FCF/Net Income) | 2.45x | 1.79x | 2.17x | 2.46x | 1.29x | 1.51x | 1.80x | 1.83x | 1.86x |
Interest Paid | 1.7B | 1.74B | 1.91B | 1.61B | 1.5B | 1.66B | 1.89B | 1.94B | 0 |
Taxes Paid | 1.21B | 872M | 849M | 1B | 2.18B | 1.18B | 1.39B | 1.84B | 0 |
HCA Key Ratios
HCA Healthcare, Inc. (HCA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | - | - | 322.65% | 317.55% | 797.03% | 1062.21% | 713.31% | - |
Return on Invested Capital (ROIC) | 19.05% | 17.33% | 17.56% | 16.97% | 15.89% | 20.47% | 17.87% | 17.78% | 18.43% | 19.89% |
Gross Margin | 83.29% | 83.23% | 83.45% | 83.48% | 83.76% | 38.28% | 38.48% | 39.37% | 40.62% | 41.5% |
Net Margin | 6.97% | 5.08% | 8.11% | 6.83% | 7.28% | 11.84% | 9.37% | 8.07% | 8.16% | 8.97% |
Debt / Equity | - | - | - | - | 11.43x | 24.66x | - | 39.49x | 81.51x | - |
Interest Coverage | 4.08x | 3.64x | 4.02x | 3.84x | 4.50x | 7.46x | 5.94x | 4.98x | 5.14x | 5.37x |
FCF Conversion | 1.96x | 2.45x | 1.79x | 2.17x | 2.46x | 1.29x | 1.51x | 1.80x | 1.83x | 1.86x |
Revenue Growth | 4.57% | 5.12% | 7.02% | 9.98% | 0.38% | 14.01% | 2.52% | 7.86% | 8.67% | 7.08% |
Related:HCA Dividend History·HCA Revenue History·HCA Price History·HCA P/E History·HCA Financial Ratios·HCA Institutional Holders
HCA SEC Filings & Documents
HCA Healthcare, Inc. (HCA) SEC filings — annual & quarterly reports (10-K, 10-Q)
HCA Frequently Asked Questions
HCA Healthcare, Inc. (HCA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
HCA Healthcare, Inc. (HCA) reported $75.60B in revenue for fiscal year 2025. This represents a 280% increase from $19.91B in 1996.
HCA Healthcare, Inc. (HCA) grew revenue by 7.1% over the past year. This is steady growth.
Yes, HCA Healthcare, Inc. (HCA) is profitable, generating $6.78B in net income for fiscal year 2025 (9.0% net margin).
Dividend & Returns
Yes, HCA Healthcare, Inc. (HCA) pays a dividend with a yield of 0.78%. This makes it attractive for income-focused investors.
HCA Healthcare, Inc. (HCA) generated $7.69B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.